Company Profiles

driven by the PitchBook Platform

Avrobio

Description

Developer of transformative and life-changing gene therapies for rare diseases and cancer. The company focused on delivering step-change cell & gene therapies targeting cancer and rare disease. It also develops disruptive therapies that have the potential to transform patients' lives in a single dose.

2015

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$25M

Latest Deal Amount

$26.5M

Total Amount Raised

Description

Developer of transformative and life-changing gene therapies for rare diseases and cancer. The company focused on delivering step-change cell & gene therapies targeting cancer and rare disease. It also develops disruptive therapies that have the potential to transform patients' lives in a single dose.

Website:

www.avrobio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Healthcare Technology Systems
Other Healthcare

Primary Office

400 Technology Square 10th Floor Cambridge, MA 02139United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avrobio's full profile, request a free trial.

Avrobio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avrobio Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Avrobio Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Atlas VentureVenture CapitalMinority000 0000000 0000
Clarus VenturesVenture CapitalMinority000 0000000 0000
SV Health InvestorsVenture CapitalMinority000 0000000 0000
Atlas Venture Venture Capital
Clarus Ventures Venture Capital
SV Health Investors Venture Capital

Avrobio Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Deanna PetersenChief Business Officer
Chris Mason Ph.DChief Science Officer
Jeffrey Medin Ph.DCo-Founder
Kim Warren Ph.DHead of Operations
Kathryn McNaughtonSenior Vice President of Portfolio and Program Management
Deanna Petersen Chief Business Officer
Chris Mason Ph.D Chief Science Officer
Jeffrey Medin Ph.D Co-Founder
Kim Warren Ph.D Head of Operations
Kathryn McNaughton Senior Vice President of Portfolio and Program Management

Avrobio Board Members (6)

NameRepresentingRoleSinceContact
Info
Bruce Booth Ph.DAtlas VenturePartner000 0000
Christopher Paige Ph.DSelfCo-Founder & Board Member000 0000
Geoff MacKaySelfChief Executive Officer, President & Board Member000 0000
Joshua Resnick MDSV Health InvestorsPartner000 0000
Michael GladstoneAtlas VenturePrincipal000 0000
Bruce Booth Ph.D Partner Atlas Venture
Christopher Paige Ph.D Co-Founder & Board Member Self
Geoff MacKay Chief Executive Officer, President & Board Member Self
Joshua Resnick MD Partner SV Health Investors
Michael Gladstone Principal Atlas Venture
Request full access to PitchBook